» Articles » PMID: 28824429

The Crux of the Medicine Prices' Controversy in Pakistan

Overview
Journal Front Pharmacol
Date 2017 Aug 22
PMID 28824429
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.

Averbuch T, Esfahani M, Khatib R, Kayima J, Miranda J, Wadhera R ESC Heart Fail. 2023; 10(5):3152-3163.

PMID: 37646297 PMC: 10567666. DOI: 10.1002/ehf2.14468.


The Burden of Cancer, Government Strategic Policies, and Challenges in Pakistan: A Comprehensive Review.

Ali A, Manzoor M, Ahmad N, Aadil R, Qin H, Siddique R Front Nutr. 2022; 9:940514.

PMID: 35938114 PMC: 9355152. DOI: 10.3389/fnut.2022.940514.


A systematic review of pharmaceutical price mark-up practice and its implementation.

Lee K, Kassab Y, Taha N, Zainal Z Explor Res Clin Soc Pharm. 2022; 2:100020.

PMID: 35481119 PMC: 9031039. DOI: 10.1016/j.rcsop.2021.100020.


Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability.

Saeed A, Lambojon K, Saeed H, Saleem Z, Anwer N, Aziz M Front Pharmacol. 2022; 13:820621.

PMID: 35431962 PMC: 9010947. DOI: 10.3389/fphar.2022.820621.


Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications.

Sefah I, Ogunleye O, Essah D, Opanga S, Butt N, Wamaitha A Front Pharmacol. 2021; 11:588106.

PMID: 33628173 PMC: 7898676. DOI: 10.3389/fphar.2020.588106.


References
1.
Mendis S, Fukino K, Cameron A, Laing R, Filipe Jr A, Khatib O . The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007; 85(4):279-88. PMC: 2636320. DOI: 10.2471/blt.06.033647. View

2.
Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R . Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2008; 373(9659):240-9. DOI: 10.1016/S0140-6736(08)61762-6. View

3.
Zaidi S, Bigdeli M, Aleem N, Rashidian A . Access to essential medicines in Pakistan: policy and health systems research concerns. PLoS One. 2013; 8(5):e63515. PMC: 3661571. DOI: 10.1371/journal.pone.0063515. View

4.
Saleem F, Hassali M, Iqbal Q, Baloch M, Shanker P . Uncontrollable medicine prices in Pakistan. Lancet. 2016; 388(10060):2602. DOI: 10.1016/S0140-6736(16)32120-1. View